Leishmaniasis - Oral treatment with hexadecylphosphocholine;Leishmaniasis: Orale therapie mit hexadecylphosphocholin

Wiener Klinische Wochenschrift, Supplement

Volumn 116, Issue 4 SUPPL., 2004, Pages 24-29

  Bommer, Wolfgang ^a   Eibl, Hans J ^b   Engel, Kirsten R ^a   Kuhlencord, Armin ^d   Sindermann, Herbert ^c   Sundar, Sham ^e   Zappel, Hildegard ^f  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^c Zentaris GmbH   (Germany)

^d Labor Kuhlencord   (Germany)

^e BANARAS HINDU UNIVERSITY   (India)

^f UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Miltefosine; Oral therapy; Resistance; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B; MILTEFOSINE;

ANOREXIA; ANTINEOPLASTIC ACTIVITY; ANTIPROTOZOAL ACTIVITY; COLOMBIA; CONFERENCE PAPER; DIARRHEA; DOSE CALCULATION; DRUG EFFICACY; DRUG SAFETY; FEVER; HUMAN; INDIA; LEISHMANIA CHAGASI; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIASIS; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

ADMINISTRATION, ORAL; ADULT; ANTIPROTOZOAL AGENTS; CHILD; CLINICAL TRIALS; DRUG RESISTANCE; HUMANS; LEISHMANIASIS; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; META-ANALYSIS; PHOSPHORYLCHOLINE; RECURRENCE; TREATMENT OUTCOME;

EID: 11244282000     PISSN: 03005178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Bhattacharya SK, Jha TK, Sundar S, Thakur CP, Engel J, Sindermann H, et al (2004) Efficacy and tolerability of miltefosine for childhood visceral leishmanisis in India. CID 38: 217-221
2. Berman J (2003) Current treatment approaches to leishmaniasis. Curr Opin Infect Dis 16: 397-401
3. Bommer W, Christophel EM, Diesner K, Kaboth U, Kortenacker J, Kuhlencord A, et al (1989) Erfahrungen mit eingeschleppten viszeralen und kutanen Leishmaniasen. Dtsch Ärzteblatt 86: B-487-489
4. Bommer W (1989) Leishmaniasen. In: Graul EH, Loew D, Pütter S (Hrsg) Medicenale XIX Dermatologie und Venerologie. Medice Hausdruck, Iserlohn, S 337-369
5. Bommer W, Eibl HJ, Engel J, Engel K, Kuhlencord A (2003) Leishmaniasis: successful oral treatment with hexadecylphosphocholine (HDPC, Miltefosin). Swiss Medical Weekly 133 [Suppl 134]: 66
6. Croft SL, Neal RA, Pendergast W, Chan JH (1987) The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani. Biochem Pharmacol 36: 2633-2636
7. Eibl HJ, Unger C (1990) Hexadecylphosphocholine: a new and selective antitumor drug. Cancer Treat Rev 17: 233-242
8. Eibl HJ, Hilgard P, Unger C (1992) Alkylphosphocholines: new drugs in cancer therapy. Progress in experimental tumor research, vol 34. Karger, Basel
9. Engel J, Sindermann H, Engel K, Bommer W (2003) Alkylphosphocholines in leishmaniasis and oncology: Miltefosine the first oral treatment of Kala Azar, 4th Intern. Symposium on Pharmaceutical Chemistry, Sept. 2003, Istanbul, Turkey Abstract JL-12: 38-39
10. Engel K, Sindermann H, Fischer C, Bommer W (2002) Efficacy of Miltefosine in patients with resistant leishmaniasis. Annual Congress Swiss Soc Trop Med and Parasitology, Bern, Abstract
11. Engel K (2003) Orale Therapie der resistenten viszeralen Leishmaniasis mit Miltefosin. Inaug Dissert Göttingen (in Vorbereitung)
12. Fischer C, Engel K, Bommer W (2001) Treatment of VL/HIV co-infected patients with oral miltefosine. World Leish II Congress, Hersonissos, Crete, Abstract 21
13. Jha TK, Sundar S, Thakur CP, Bachmann P, Karbwang J, Fischer C, et al (1999) Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med 341: 1795-1800
14. Kuhlencord A, Maniera T, Eibl H, Unger C (1992) Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Anitmicrob Agents Chemother 36: 1630-1634
15. Soto J, Toledo J, Gutierrez P, Nicholis RS, Padilla J, Engel J, et al (2001) Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis 33: 57-61
16. Soto J, Arana B, Toledo J, Rizzo N, Vega JC, Daiz A, et al (2004) Miltefosine for new world cutaneous leishmaniasis. Clin Infect Dis 38: 1266-1272
17. Sundar S, Rosenkaimer F, Makharia MK, Goyal AK, Mandal AK, Voss A, et al (1998) Trial of oral miltefosine for visceral leishmaniasis. Lancet 352: 1821-1823
18. Sundar S, Gupta LB, Makharia MK, Singh MK, Voss A, Rosenkaimer F, et al (1999) Oral treatment of visceral leishmaniasis with miltefosine. Ann Trop Med Parasitol 93: 589-597
19. Sundar S, Jha TK, Thakur CP, Engel J, Sindermann H, Fischer C, et al (2002) Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 347: 1739-1746
20. Sundar S, Jha TK, Sindermann H, Junge K, Bachmann P, Berman J (2003) Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis. Pediatr Infect Dis J 22: 434-438